PHAT Phathom Pharmaceuticals, Inc.
$12.23
▼ 3.47%
39
Value
16
P/E-6.38
8
P/B-2.98
5
P/S4.76
48
EV/EBITDA-8.30
5
Growth
67
Revenue Growth216.9%
100
EPS Growth42.7%
46
FCF Growth37.5%
48
Momentum
63
12-Month Return409.6%
100
3-Month Return-1.5%
58
1-Month Return3.6%
60
RSI (14)42.90
50
50/200 MABearish
30
Profitability
23
ROE39.2%
59
ROA-51.6%
0
Gross Margin84.9%
69
Operating Margin-47.1%
0
Net Margin-76.8%
0
FCF Yield-10.0%
0
Risk
25
Beta0.57
55
60-Day Volatility66.9%
0
QScore Analysis